Kim, S.-H.; Gwak, H.-S.; Lee, Y.; Park, N.-Y.; Han, M.; Kim, Y.; Kim, S.-Y.; Kim, H.J.
Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases. Cancers 2021, 13, 2227.
https://doi.org/10.3390/cancers13092227
AMA Style
Kim S-H, Gwak H-S, Lee Y, Park N-Y, Han M, Kim Y, Kim S-Y, Kim HJ.
Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases. Cancers. 2021; 13(9):2227.
https://doi.org/10.3390/cancers13092227
Chicago/Turabian Style
Kim, Su-Hyun, Ho-Shin Gwak, Youngjoo Lee, Na-Young Park, Mira Han, Yeseul Kim, So-Yeon Kim, and Ho Jin Kim.
2021. "Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases" Cancers 13, no. 9: 2227.
https://doi.org/10.3390/cancers13092227
APA Style
Kim, S.-H., Gwak, H.-S., Lee, Y., Park, N.-Y., Han, M., Kim, Y., Kim, S.-Y., & Kim, H. J.
(2021). Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases. Cancers, 13(9), 2227.
https://doi.org/10.3390/cancers13092227